Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Compass Pathways Plc ADR (CMPS)

Compass Pathways Plc ADR (CMPS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
World’s Richest Man Says Psychedelics Could Make a Real Difference in Mental Health

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – June 15, 2022 – Elon Musk believes that psychedelics and other plant-based drugs are better than pharma meds in treating...

CYBN.NE : 0.770 (+4.05%)
MMED.NE : 0.940 (+1.08%)
TSLA : 734.76 (-0.32%)
CYBN : 0.6150 (+4.70%)
MNMD : 0.7128 (+1.96%)
CMPS : 10.90 (+1.40%)
SEEL : 0.6600 (-0.17%)
NUMI.TO : 0.2600 (unch)
NUMIF : 0.2018 (-1.66%)
World's Richest Man Says Psychedelics Could Make a Real Difference in Mental Health

/PRNewswire/ -- Elon Musk believes that psychedelics and other plant-based drugs are better than pharma meds in treating a number of mental health conditions....

CMPS : 10.90 (+1.40%)
NUMI.TO : 0.2600 (unch)
CYBN : 0.6150 (+4.70%)
MNMD : 0.7128 (+1.96%)
SEEL : 0.6600 (-0.17%)
NUMIF : 0.2018 (-1.66%)
Rising Cases Of Mental Health Disorders of Stress, Anxiety & Addiction Fueling Need for Central Nervous System Therapeutics

Palm Beach, FL – June 7, 2022 – FinancialNewsMedia.com News Commentary – The global Central Nervous System (CNS) treatments and its market revenues had been steadily growing pre-pandemic and are...

SPRC : 2.23 (unch)
CMND.CN : 0.350 (-2.78%)
CMNDF : 0.2835 (-29.13%)
BIIB : 213.57 (+0.77%)
AMGN : 244.85 (-0.21%)
CMPS : 10.90 (+1.40%)
DNLI : 30.75 (-0.58%)
Wall Street Analysts See a 781% Upside in COMPASS Pathways PLC Sponsored ADR (CMPS): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 781.4% in COMPASS Pathways PLC Sponsored ADR (CMPS). While the effectiveness of this highly sought-after metric...

CMPS : 10.90 (+1.40%)
COMPASS Pathways presents largest ever study of psilocybin therapy, at American Psychiatric Association annual meeting

Positive data from phase IIb study shows potential of COMP360 psilocybin therapy in treatment-resistant depression London, UK – 23 May...

CMPS : 10.90 (+1.40%)
COMPASS Pathways to participate in upcoming Citi’s Biopharma Virtual Co-Panel Day and H.C. Wainwright Global Investment Conference

LONDON, May 12, 2022 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to...

CMPS : 10.90 (+1.40%)
COMPASS Pathways plc (CMPS) Q1 2022 Earnings Call Transcript

CMPS earnings call for the period ending March 31, 2022.

CMPS : 10.90 (+1.40%)
COMPASS Pathways plc announces first quarter 2022 financial results and business highlights

LONDON, May 10, 2022 (GLOBE NEWSWIRE) -- Highlights: End of phase II meeting held with FDAAward of Innovation Passport as part of...

CMPS : 10.90 (+1.40%)
COMPASS Pathways to fund study of COMP360 psilocybin in autistic adults

London, UK – 9 May 2022 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to...

CMPS : 10.90 (+1.40%)
Catalio Capital Management Raises $381 Million for Oversubscribed Third Life Sciences Fund

Catalio Capital Management, LP (“Catalio”), a leading multi-strategy life sciences investment firm, today announced the successful close of its third venture fund, Catalio Nexus Fund III (“Fund III”...

RXRX : 8.25 (-8.23%)
CMPS : 10.90 (+1.40%)
ATAI : 3.66 (-3.43%)
EXAS : 44.10 (-2.33%)
LH : 241.31 (-0.52%)

Barchart Exclusives

Bear Call Spread Screener Results For June 28th
This Bear Call Spread on NVDA involves selling the 170 August call and buying the 175 call. That spread could be sold for around $2.20 which means the trader would receive $220 into their account. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar